Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Generex Biotechnology Corp (GNBT) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Generex Biotechnology Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 1059784.
Total stock buying since 2014: $11,797.
Total stock sales since 2014: $0.
Total stock option exercises since 2014: $21,304.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2018 | 9,800 | $11,797 | 0 | $0 | 0 | $0 |
2016 | 0 | $0 | 0 | $0 | 14,890,033 | $14,890 |
2015 | 0 | $0 | 0 | $0 | 5,874,162 | $5,874 |
2014 | 0 | $0 | 0 | $0 | 542,154 | $540 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2018-12 | 9,800 | $11,797 | 0 | $0 | 0 | $0 |
2016-02 | 0 | $0 | 0 | $0 | 14,890,033 | $14,890 |
2015-04 | 0 | $0 | 0 | $0 | 5,874,162 | $5,874 |
2014-10 | 0 | $0 | 0 | $0 | 542,154 | $540 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2018-12-07 | Haines Harold Gray (Other) | Buy | 8,300 | 1.04 | 8,632 |
2018-12-04 | Haines Harold Gray (Other) | Buy | 1,500 | 2.11 | 3,165 |
2016-02-09 | Fletcher Mark (President & CEO) | Option Ex | 14,890,033 | .00 | 14,890 |
2015-04-27 | Barratt John P | Option Ex | 5,874,162 | .00 | 5,874 |
2014-10-06 | Mcgee Brian (Director) | Option Ex | 35,714 | .00 | 35 |
2014-10-06 | Barratt John P (Director) | Option Ex | 35,714 | .00 | 35 |
2014-10-06 | Fletcher Mark (President & CEO) | Option Ex | 470,726 | .00 | 470 |
Insider trading activities including stock purchases, stock sales, and option exercises of GNBT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Generex Biotechnology Corp (symbol GNBT, CIK number 1059784) see the Securities and Exchange Commission (SEC) website.